Financials
- Market Capitalization 5.42 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.17
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4804 | CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.84 USD | 0.00% | -6.67% | -11.58% | -75.00% | 5.54 M USD | ||
| 4805 | AIM AIM ImmunoTech Inc. Common Stock | 0.18 USD | 0.00% | -5.26% | -18.18% | -93.03% | 5.48 M USD | ||
| 4812 | LEXX Lexaria Bioscience Corp. - Common Stock | 3.27 USD | -1.51% | +11.60% | -17.84% | +263.33% | 5.40 M USD | ||
| 4819 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.90 USD | +25.00% | +22.58% | -3.55% | -14.60% | 5.31 M USD |